Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 16

Showing 16 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 35
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 12
Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline:in vitro,in silicostudies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors
Saquib Jalil, Zahid Hussain, Syed Mobashir Ali Abid, et al.
RSC Advances (2024) Vol. 14, Iss. 13, pp. 8905-8920
Open Access | Times Cited: 7
Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides
Iván Sanchis, Florencia Aimaretti, Matias Lupotti, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108202-108202
Closed Access
Synthesis of novel aryl-substituted 2-aminopyridine derivatives by the cascade reaction of 1,1-enediamines with vinamidinium salts to develop novel anti-Alzheimer agents
Sama Loori, Hormoz Pourtaher, Abdolmohammad Mehranpour, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies
Sunny Rathee, D. Sen, Vishal Pandey, et al.
Current Drug Targets (2024) Vol. 25, Iss. 11, pp. 752-774
Closed Access | Times Cited: 2
β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
Roberto A. Galeana-Ascencio, Liliana Mendieta, Ilhuicamina Daniel Limón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8164-8164
Open Access | Times Cited: 7
Peptidomimetics based on ammonium decasubstituted pillar[5]arenes: Influence of the alpha-amino acid residue nature on cholinesterase inhibition
Anastasia Nazarova, Pavel Padnya, Alexandra Kharlamova, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106927-106927
Closed Access | Times Cited: 7
Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease
J. Domingo Sánchez, Andrés R. Alcántara, Juan F. González, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1413-1428
Closed Access | Times Cited: 5
Chemical characterization and biological properties of oyster and shiitake mushrooms extracts and their liposomal formulations.
Çağlar Macit, Ozan Emre Eyüpoğlu, Meltem Macit, et al.
Food Bioscience (2024) Vol. 61, pp. 104737-104737
Closed Access | Times Cited: 1
Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance
Tapan Behl, Ashishkumar Kyada, R Roopashree, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102556-102556
Closed Access | Times Cited: 1
Synthesis, Antiacetylcholinesterase Activity, and Molecular Dynamics Simulation of Aporphine–benzylpyridinium Conjugates
Nisachon Khunnawutmanotham, Pichjira Sooknual, Paratchata Batsomboon, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 132-142
Closed Access | Times Cited: 2
In-silico virtual screening approaches and molecular dynamics simulation of quercetin derivatives for novel anti-Alzheimer drug candidates: Computational biology
Shalini Sharma, Surabhi Johari, Shweta Dang
(2024), pp. 136-149
Closed Access
Investigating the Potency of Erythrina‒Derived Flavonoids as Cholinesterase Inhibitors and Free Radical Scavengers Through in silico Approach: Implications for Alzheimer’s Disease Therapy
Abd. Wahid Rizaldi Akili, Nisrina Azizah Thurfah, Ari Hardianto, et al.
Advances and Applications in Bioinformatics and Chemistry (2024) Vol. Volume 17, pp. 107-118
Open Access
Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders
Amera E. Shaaban, Ahmed R. Ali, Seif N. Ayyad, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108075-108075
Closed Access
Design, synthesis, and evaluation of benzylpiperidine-derived hydrazones as dual inhibitors of monoamine oxidases and acetylcholinesterase
Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi
Medicinal Chemistry Research (2024)
Closed Access
Page 1

Scroll to top